Insulin-like growth factor-binding protein-1 in cervical secretion as a predictor of preterm delivery

Citation
M. Kekki et al., Insulin-like growth factor-binding protein-1 in cervical secretion as a predictor of preterm delivery, ACT OBST SC, 80(6), 2001, pp. 546-551
Citations number
18
Categorie Soggetti
Reproductive Medicine
Journal title
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
ISSN journal
00016349 → ACNP
Volume
80
Issue
6
Year of publication
2001
Pages
546 - 551
Database
ISI
SICI code
0001-6349(200106)80:6<546:IGFPIC>2.0.ZU;2-U
Abstract
Background. The aim of the study was to evaluate whether the phosphorylated isoforms of insulin-like growth factor-binding protein-1 (IGFBP-1), a prot ein produced by the decidua, can be detected in cervical secretions of preg nant women with preterm uterine contractions, and whether their presence pr edicts an increased risk of preterm delivery. Methods. A prospective analysis of sixty-three women who presented with pre term labor but intact fetal membranes at weeks 22-36+6 days of gestation at the Antenatal clinic at the Department of Obstetrics and Gynecology, Helsi nki University Central Hospital. Phosphorylated IGFBP-1 (phIGFBP-1) was mea sured in cervical swab samples obtained at presentation, using an immunoenz ymometric assay. The values greater than or equal to 10 mug/L were consider ed as positive. In addition, 58 asymptomatic women at the same gestational stage were studied as controls. Multiple logistic regression was applied to control for confounding variables and to obtain adjusted odds ratios. Results. The concentration of phIGFBP-1 in cervical samples ranged from und etectable to 95 mug/L. In 17 of the 63 (27%) women with preterm labor it wa s greater than or equal to 10 pg/L. Seven of these 17 (41%) women with a po sitive phIGFBP-1 result delivered preterm, all before 35 weeks of gestation . Among the women with preterm labor and a negative phIGFBP-1 result, three of the 46 (7%) delivered before 37 weeks of gestation (adjusted OR 24, 95% CI 1.2-487), but all after 35 weeks of gestation. In the asymptomatic cont rol population three out of 58 (5%) women had a positive cervical phIGFBP-1 test result but none delivered preterm. Among the controls with a negative cervical phIGFBP-1 test result (55 of 58, 95%), one woman delivered preter m (1 of 55, 2%). Conclusions. Pregnant women who are in preterm labor with intact fetal memb ranes and who have a positive phIGFBP-1 test result in cervical secretion h ave an increased risk of preterm delivery.